The global infusion pumps market is projected to reach USD 20.5 billion by 2027 from USD 14.7 billion in 2022, at a CAGR of 7.0% from 2022 to 2027. The growth of the global infusion pumps market is driven by a increasing incidence of chronic diseases and the rapid growth in the geriatric population, rising demand for ambulatory infusion pumps, and the growing volume of surgical procedures performed. Emerging economies such as China, India, and Brazil offer significant growth opportunities for players in the infusion pumps market. Smart pump-EMR interoperability and growing focus on specialty pumps are some of the current trends in infusion pumps market. However, factors such as product recalls, stringent regulatory requirements for new products, and the increasing adoption of refurbished infusion pumps may restrain market growth to a certain extent during the forecast period.
Prominent players in the infusion pumps market are Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), ICU Medical (US), Fresenius Kabi (Germany), Medtronic plc (Ireland), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Terumo Corporation (Japan), Insulet Corporation (US), Ypsomed Holding AG (Switzerland), Tandem Diabetes Care (US), JMS Co., Ltd. (Japan), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Zyno Medical LLC (US), Roche Diagnostics (Switzerland), Teleflex, Inc. (US), Shenzhen Mindray Bio-Medical Electronics co., ltd. (China), Epic Medical (Singapore), SOOIL Development Co., Ltd. (South Korea), Shenzhen MedRena Biotech Co., Ltd. (China), CODAN Medizinische Geräte GmbH & Co KG (Germany), and Eitan Medical (Israel). These companies adopted strategies such as acquisitions, partnerships, expansions, and product launches to enhance their presence in the infusion pumps market.
To know about the assumptions considered for the study download the pdf brochure
Becton, Dickinson and Company (US) is a leader in the global infusion pumps market. It held a share of ~14–16% in 2021. The company offers a wide range of products, including volumetric pumps, syringe pumps, and PCA pumps, under its market-leading brand—Alaris. The company also provides dedicated disposables and non-dedicated accessories for infusion products. In 2019, BD submitted a 510(k) application for the BD Alaris System to bring its regulatory clearance up to date, implement updated features, and address open recall issues, including a new version of the BD Alaris System software that will provide clinical, operational, and cybersecurity updates. The company has a strong manufacturing and distribution footprint worldwide, enabling it to serve customers in the Americas, Africa, Europe, the Middle East, and the Asia Pacific.
Baxter International accounted for 13–15% of the infusion pumps market in 2021. The company has one global business unit (GBU), which is subsegmented into Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies, BioPharma Solutions, Patient Support Systems, Front Line Care, Surgical Solutions and Others, and Others. The company offers infusion pumps and related accessories through the Medication Delivery segment. The company has distribution and production facilities in more than 20 countries and markets its products in more than 100 countries. Baxter’s leadership in the market can be attributed to its efficient sales network and expansion strategies in the US, Europe, and Asia. The company focuses on integrating its infusion pumps with hospital networking systems to improve the quality of care and reduce medication errors. In August 2022, the company received US FDA approval for the new Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software.
B. Braun accounted for 11–12% of the global infusion pumps market in 2021. B. Braun offers a wide range of infusion pumps and accessories. Over the years, the company has gained a greater market share through significant investments in expanding its geographic reach. The company focuses on integrating its infusion pumps with EHRs. In this regard, in October 2019, B. Braun collaborated with STANLEY Healthcare (US) to integrate and deploy its Space Infusion Pump Systems along with DoseTrac Infusion Management Software. B. Braun has a strong presence in about 64 countries across North America, Europe, the Asia Pacific, Africa, the Middle East, and Latin America. It has 299 consolidated companies across the globe. The company’s major manufacturing sites are in the US, Germany, Brazil, China, France, India, Malaysia, Poland, Switzerland, Spain, and Hungary.
Infusion Pump Market by Product (Accessories (Dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory, Enteral)) Technology (Traditional, Specialty) Application (Cancer, Diabetes, Pediatric) & Setting (Hospital, Home care) - Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE